Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

350 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD44 and OTP are strong prognostic markers for pulmonary carcinoids.
Swarts DR, Henfling ME, Van Neste L, van Suylen RJ, Dingemans AM, Dinjens WN, Haesevoets A, Rudelius M, Thunnissen E, Volante M, Van Criekinge W, van Engeland M, Ramaekers FC, Speel EJ. Swarts DR, et al. Among authors: dingemans am. Clin Cancer Res. 2013 Apr 15;19(8):2197-207. doi: 10.1158/1078-0432.CCR-12-3078. Epub 2013 Feb 26. Clin Cancer Res. 2013. PMID: 23444222 Free article.
Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib.
van den Boogaart VE, de Lussanet QG, Houben RM, de Ruysscher D, Groen HJ, Marcus JT, Smit EF, Dingemans AM, Backes WH. van den Boogaart VE, et al. Among authors: dingemans am. Lung Cancer. 2016 Mar;93:20-7. doi: 10.1016/j.lungcan.2015.12.009. Epub 2015 Dec 30. Lung Cancer. 2016. PMID: 26898610 Clinical Trial.
Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI.
de Langen AJ, van den Boogaart V, Lubberink M, Backes WH, Marcus JT, van Tinteren H, Pruim J, Brans B, Leffers P, Dingemans AM, Smit EF, Groen HJ, Hoekstra OS. de Langen AJ, et al. Among authors: dingemans am. J Nucl Med. 2011 Jan;52(1):48-55. doi: 10.2967/jnumed.110.078261. Epub 2010 Dec 13. J Nucl Med. 2011. PMID: 21149474 Free article. Clinical Trial.
Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome.
Swarts DR, Claessen SM, Jonkers YM, van Suylen RJ, Dingemans AM, de Herder WW, de Krijger RR, Smit EF, Thunnissen FB, Seldenrijk CA, Vink A, Perren A, Ramaekers FC, Speel EJ. Swarts DR, et al. Among authors: dingemans am. Am J Pathol. 2011 Sep;179(3):1129-37. doi: 10.1016/j.ajpath.2011.05.028. Epub 2011 Jul 16. Am J Pathol. 2011. PMID: 21763262 Free PMC article.
350 results